Trade names Takecab Bioavailability Unknown Biological half-life 7.7 h ChemSpider ID 13112797 Excretion Renal | ATC code None Protein binding 80% Molar mass 461.46 g/mol Trade name Takecab | |
 | ||
Metabolism | ||
Vonoprazan fumarate is a first-in-class potassium-competitive acid blocker. It was approved in the Japanese market in February 2015.
Vonoprazan can be used for the treatment of gastroduodenal ulcer (including some drug-induced peptic ulcers) and reflux esophagitis, and can be combined with antibiotics for the eradication of Helicobacter pylori.
References
Vonoprazan Wikipedia(Text) CC BY-SA